Voyager Therapeutics shares are trading lower after the company announced the pricing of its $100 million offering of 7,777,778 shares at $9 per share.
Portfolio Pulse from Benzinga Newsdesk
Voyager Therapeutics has announced the pricing of its $100M offering, which consists of 7,777,778 shares at $9 per share, causing its stock to trade lower.
January 05, 2024 | 4:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Voyager Therapeutics' stock is trading lower due to the announcement of a $100M share offering priced at $9 per share.
The announcement of a new share offering typically dilutes the value of existing shares, leading to a short-term decrease in stock price. The pricing of the offering at $9 per share is a concrete figure that investors can use to assess the impact of the dilution.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100